1. Home
  2. LOOP vs ESLA Comparison

LOOP vs ESLA Comparison

Compare LOOP & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

HOLD

Current Price

$1.02

Market Cap

58.1M

Sector

Industrials

ML Signal

HOLD

Logo Estrella Immunopharma Inc.

ESLA

Estrella Immunopharma Inc.

HOLD

Current Price

$1.30

Market Cap

48.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOOP
ESLA
Founded
2010
2021
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.1M
48.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LOOP
ESLA
Price
$1.02
$1.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
73.4K
101.4K
Earning Date
01-15-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,112,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$41.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10901.98
N/A
52 Week Low
$0.85
$0.73
52 Week High
$2.29
$3.15

Technical Indicators

Market Signals
Indicator
LOOP
ESLA
Relative Strength Index (RSI) 49.93 36.78
Support Level $0.95 $1.45
Resistance Level $1.04 $1.60
Average True Range (ATR) 0.07 0.17
MACD 0.02 -0.02
Stochastic Oscillator 97.14 16.67

Price Performance

Historical Comparison
LOOP
ESLA

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Share on Social Networks: